Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

ATMU May 1, 2026

Atmus Filtration Technologies Q1 2026 Earnings Call - Koch Filter Acquisition Drives 14.6% Revenue Growth and Expands Industrial Footprint

Atmus Filtration Technologies delivered a strong first quarter, reporting $478 million in sales, up 14.6% year-over-year, primarily driven by the strategic acquisition of Koch Filter. The deal marks a...

  • Atmus Filtration Technologies reported Q1 2026 sales of $478 million, a 14.6% increase from $417 million in Q1 2025, driven largely by the January 2026 acquisition of Koch Filter.
  • The company completed its first major strategic acquisition, Koch Filter, establishing a new Industrial Solutions segment and expanding into commercial industrial HVAC, data centers, and healthcare.
  • Koch Filter contributed $38 million in Q1 sales and $8 million in adjusted EBITDA, achieving a 21.9% margin and 6% revenue growth, signaling strong initial integration and cultural alignment.
  • +7 more takeaways
CNO May 1, 2026

CNO Financial Group Q1 2026 Earnings Call - Operating Earnings Surge 33% on Sales Momentum and ROE Ambition

CNO Financial Group delivered a forceful start to 2026, with operating EPS jumping 33% to $1.05. The growth is not a fluke. It is the compounding result of a disciplined middle-market strategy, a capt...

  • Operating earnings per diluted share rose 33% to $1.05, a clear sign of underlying business strength.
  • Total new annualized premiums climbed 11%, marking the 15th consecutive quarter of sales growth.
  • Producing agent count increased 3%, extending a 13-quarter streak of distribution expansion.
  • +7 more takeaways
CVEO May 1, 2026

Civeo Corporation Q1 2026 Earnings Call - Revenue Guidance Raised Amidst Margin Pressure from Global Energy Dislocations

Civeo delivered a formidable start to 2026, crushing expectations with a 20% revenue surge and a 78% jump in Adjusted EBITDA. The company is riding a wave of improved Canadian occupancy and a booming ...

  • Consolidated revenue surged 20% year-over-year to $172.7 million, driven by higher occupancy in Canada and the full-quarter contribution from acquired Australian villages.
  • Adjusted EBITDA jumped 78% to $22.5 million, reflecting significant margin expansion in Canada and strong performance in the Australian integrated services segment.
  • Management raised the low end of full-year 2026 revenue guidance to $675 million, citing momentum in Australia and a recovering Canadian business, while maintaining EBITDA guidance at $85-$90 million due to inflationary pressures.
  • +7 more takeaways
D May 1, 2026

Dominion Energy Q1 2026 Earnings Call - Virginia Grid Expansion and CVOW Execution Drive Growth

Dominion Energy reported a strong first quarter, delivering $0.95 in operating earnings per share and reaffirming its 5% to 7% annual growth guidance. The utility is navigating a complex macro environ...

  • First quarter operating earnings reached $0.95 per share, with GAAP earnings at $0.69 per share, marking a solid start to the year.
  • Management reaffirmed full-year guidance, targeting 5% to 7% annual earnings growth with a bias toward the upper half starting in 2028.
  • Virginia legislation now requires Dominion to petition for 20 gigawatts of short- and long-term grid-scale energy storage by 2045, up from 3 gigawatts by 2035.
  • +7 more takeaways
IRMD May 1, 2026

IRadimed Q2 2025 Earnings Call - Record Backlog and $100M Revenue Run Rate Target

IRadimed delivered its 16th consecutive record quarter in Q2 2025, with revenue rising 14% to $20.4 million and EPS climbing 18%. The company’s MRI-compatible IV pump line drove the growth, supported ...

  • IRadimed reported Q2 2025 revenue of $20.4 million, a 14% year-over-year increase, marking its 16th consecutive record quarter.
  • GAAP diluted EPS rose 18% to $0.45, while non-GAAP diluted EPS was $0.49, reflecting strong earnings power.
  • MRI-compatible IV pump revenue surged 19% to $8.2 million, leading overall growth across all product lines.
  • +7 more takeaways
NUTX May 1, 2026

Nutex Health Q1 2026 Earnings Call - Internalizing Hospital Development to Fuel Scalable Expansion

Nutex Health delivered a quarter of steady volume growth and improved profitability, underscored by a 121% surge in net income to $46.8 million and a 3.1% rise in patient visits. The company’s core mi...

  • Total revenue rose 2.2% year-over-year to $216.5 million, driven by a 1.8% increase in hospital division revenue to $207.6 million.
  • Net income surged 121% to $46.8 million compared to $21.2 million in Q1 2025, reflecting improved bottom-line performance despite revenue headwinds.
  • Adjusted EBITDA declined 21% to $57.6 million, primarily due to the timing of IDR expense recognition in the prior year rather than operational deterioration.
  • +7 more takeaways
CWST May 1, 2026

Casella Waste Systems Q1 2026 Earnings Call - Margin Expansion and Acquisition Momentum Drive Strong Start to 2026

Casella Waste Systems delivered a robust first quarter, beating budget on both the top and bottom lines while expanding adjusted EBITDA margins by 50 basis points. Revenue grew 9.6% year-over-year to ...

  • Revenue grew 9.6% year-over-year to $457.3 million, driven by $23.9 million from acquisitions and $16.2 million from same-store growth (3.9%).
  • Adjusted EBITDA increased 12.3% year-over-year to $97.1 million, with adjusted EBITDA margin expanding 50 basis points to 21.2%.
  • Solid waste pricing rose 5.1% overall, with collection pricing up 5.3% and disposal pricing up 4.7%, reflecting strong demand and disciplined contract management.
  • +7 more takeaways
TPG May 1, 2026

TPG Q1 2026 Earnings Call - Fee-Related Earnings Cross $1 Billion Milestone on 36% Growth

TPG delivered a forceful start to 2026, crossing the $1 billion annualized fee-related earnings threshold for the first time. Fee-related revenue grew 17% year-over-year, while after-tax distributable...

  • Fee-Related Earnings (FRE) crossed $1 billion on a trailing twelve-month basis for the first time, growing 36% year-over-year in Q1 2026.
  • After-tax distributable earnings per share grew 46% to $0.70, with total AUM rising 22% to $306 billion.
  • Capital formation surged 75% year-over-year, with over $10 billion raised in Q1, including $4.4 billion in credit and $4.9 billion in private equity.
  • +7 more takeaways
EHC May 1, 2026

Encompass Health Q1 2026 Earnings Call - Raised Guidance Amid Capacity Constraints and Clinical Turnover Wins

Encompass Health delivered a strong start to 2026, with Q1 revenue rising 9% to $1.59 billion and adjusted EBITDA climbing 11.2% to $348.8 million. The company raised its full-year guidance, citing ro...

  • Q1 2026 revenue increased 9% to $1.59 billion, with adjusted EBITDA up 11.2% to $348.8 million, driven by 4.3% discharge growth and favorable patient mix.
  • Encompass Health raised its full-year 2026 guidance, now expecting net operating revenue of $6.375 billion to $6.470 billion and adjusted EPS of $5.89 to $6.11.
  • Record-low RN turnover of 17.8% and therapist turnover of 6.4% contributed to a 9.4% year-over-year decline in premium labor costs, saving $2.7 million in Q1.
  • +7 more takeaways
GTES May 1, 2026

Gates Industrial Corporation Q1 2026 Earnings Call - ERP Transition Costs Offset by Strong Order Growth and Data Center Momentum

Gates Industrial reported a 2.9% core sales decline in Q1 2026, driven by a disruptive ERP rollout in Europe and two fewer working days, but underlying demand trends are stabilizing with mid-single-di...

  • Q1 core sales fell 2.9% to $851 million, primarily due to a 600 basis point headwind from Europe's ERP transition and two fewer working days, masking underlying strength.
  • Adjusted EBITDA of $177 million delivered a 20.8% margin, down 130 basis points year-over-year, reflecting temporary ERP inefficiencies and higher SG&A costs during the hypercare phase.
  • Europe's business has stabilized post-ERP, with March revenues matching prior-year levels and full revenue recovery achieved by April, eliminating the need for guidance revisions.
  • +7 more takeaways